China vs Guinea-Bissau: Population requiring preventive chemotherapy for schistosomiasis
China
156,162
in 2018
Guinea-Bissau
399,321
in 2024
China rank
44th
Guinea-Bissau rank
41st
Population requiring preventive chemotherapy for schistosomiasis over time
- China
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 399,321 against 156,162 in China, a difference of 243,159.
That makes Guinea-Bissau's figure about 2.6 times China's.
Across all 9 years both countries report, Guinea-Bissau has been ahead every year.
China ranks 44th and Guinea-Bissau ranks 41st of 52 countries.
Guinea-Bissau has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, China or Guinea-Bissau?
- Guinea-Bissau, at 399,321 against 156,162 in China as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between China and Guinea-Bissau?
- 243,159, with Guinea-Bissau ahead.
- How many years of comparable data are there for China and Guinea-Bissau?
- 9 years are reported by both, from 2010 to 2018.
- How do China and Guinea-Bissau rank globally for population requiring preventive chemotherapy for schistosomiasis?
- China ranks 44th and Guinea-Bissau ranks 41st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.